Lack of clinically relevant interaction between desloratadine and erythromycin

Clinical Pharmacokinetics

Volumn 41, Issue SUPPL. 1, 2002, Pages 29-35

  Banfield, C ^a   Hunt, T ^b   Reyderman, L ^a   Statkevich, P ^a   Padhi, D ^a   Affrime, M ^a  

^a MERCK RESEARCH LABORATORIES   (United States)

^b Pharmaceutical Product Development   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

3 HYDROXYDESLORATADINE; CYTOCHROME P450 3A4; CYTOCHROME P450 INHIBITOR; DESLORATADINE; DRUG METABOLITE; ERYTHROMYCIN; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOSE RESPONSE; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG INDUCED DISEASE; DRUG SAFETY; DRUG TOLERABILITY; ELECTROCARDIOGRAM; FEMALE; GASTROINTESTINAL SYMPTOM; HUMAN; HUMAN EXPERIMENT; MALE; NORMAL HUMAN; PRIORITY JOURNAL; QT INTERVAL; RANDOMIZED CONTROLLED TRIAL; SYNCOPE;

EID: 0036071091     PISSN: 03125963     EISSN: None     Source Type: Journal    
DOI: 10.2165/00003088-200241001-00005     Document Type: Article

References (11)

1. Second-generation antihistamines: The risk of ventricular arrhythmias
2. + channels
3. Block of HERG potassium channels by the antihistamine astemizole and its metabolites desmethylastemizole and norastemizole
4. Blockade of HERG channels expressed in Xenopus oocytes by the histamine receptor antagonists terfenadine and astemizole
5. The current cardiac safety situation with antihistamines
6. Arrhythmogenic mechanisms of non-sedating antihistamines
7. Torsades de pointes induced by erythromycin and terfenadine
8. Changes in the pharmacokinetics and electrocardiographic pharmacodynamics of terfenadine with concomitant administration of erythromycin
9. Preclinical pharmacology of desloratadine, a selective and nonsedating histamine HI receptor antagonist: 1st communication: Receptor selectivity, antihistaminic activity, and antiallergenic affects
10. Efficacy and tolerability of once-daily 5mg destoratadine, an H1-receptor antagonist, in patients with seasonal allergic rhinitis. Assessment during the spring and fall allergy seasons
11. A comparison of the two one-sided test procedure and the power approach for assessing the bioequivalence of average bioavailability